Australia markets close in 3 hours 34 minutes
  • ALL ORDS

    7,709.40
    +9.00 (+0.12%)
     
  • ASX 200

    7,496.50
    +14.80 (+0.20%)
     
  • AUD/USD

    0.7057
    -0.0005 (-0.07%)
     
  • OIL

    77.80
    -0.10 (-0.13%)
     
  • GOLD

    1,922.80
    -0.10 (-0.01%)
     
  • BTC-AUD

    32,342.02
    -1,471.40 (-4.35%)
     
  • CMC Crypto 200

    516.94
    -20.93 (-3.89%)
     
  • AUD/EUR

    0.6497
    +0.0004 (+0.06%)
     
  • AUD/NZD

    1.0898
    -0.0011 (-0.10%)
     
  • NZX 50

    12,031.62
    -2.55 (-0.02%)
     
  • NASDAQ

    11,912.39
    -254.21 (-2.09%)
     
  • FTSE

    7,784.87
    +19.72 (+0.25%)
     
  • Dow Jones

    33,717.09
    -260.99 (-0.77%)
     
  • DAX

    15,126.08
    -23.95 (-0.16%)
     
  • Hang Seng

    22,190.27
    +120.54 (+0.55%)
     
  • NIKKEI 225

    27,415.32
    -18.08 (-0.07%)
     

Is Novavax Stock a Buy Now?

Is Novavax Stock a Buy Now?

Novavax (NASDAQ: NVAX) investors are looking at a share price decline of more than 90% over the past 12 months, and the shares are now trading close to their 52-week low. Importantly, Gavi has paid Novavax $700 million in the last two years, and its $350 million payment in 2021 accounted for a large fraction of the biotech's $1.1 billion in total revenue for the year.